Press Release

IQVIA receives 2024 Best in KLAS award for Acute Care EMR in Asia and Oceania for the Second Consecutive Year

Mar 04, 2024

LOCATION, 7 February 2024 - IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced that IQVIA Hospital Information System received the 2024 Best in KLAS award for Acute Care EMR, Asia and Oceania, category for the second consecutive year. The award from KLAS Research comes as part of its annual assessment of healthcare industry software and professional services.

“For the second year running, we are thrilled to be honored with the recognition from our clients for the IQVIA Hospital Information System, solidifying its position as the top performing EMR solution in the APAC market. This prestigious award underscores our continued commitment to innovation, timely delivery, and continuous support for our valued customers,” said Peter Lane, Senior Vice President & General Manager, Africa, Middle East and South Asia, IQVIA.

IQVIA Hospital Information System is a cloud-based solution for healthcare institutions designed to increase provider efficiency, reduce costs, facilitate regulatory compliance, and promote standardization of care.

The 2024 Best in KLAS report highlights the top-performing healthcare IT solutions as determined by extensive evaluations and conversations with thousands of healthcare providers. The 2024 Best in KLAS report is available now to KLAS subscribers.

For more information about IQVIA Hospital Information System, visit here.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

Contact Us